Kingfa Science & Technology (India) Limited (KINGFA) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Kingfa Science & Technology (India) Limited ₹2,324, price ₹6,587, upside -64.7%, quality 46 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Kingfa Science & Technology (India) Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range ₹760.66 – ₹6,587 · fair‑value band ₹1,743 – ₹2,905 · the ₹6,587 price screens above the ₹2,324 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Kingfa Science & Technology (India) in your weekly email
Every Wednesday you see whether Kingfa Science & Technology (India) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India.
Show more
Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India. It also offers engineering plastics including ABS, HIPS, PA, PBT, PC and their alloys; biodegradable nitrile gloves and protective coverall; thermoplastic elastomers under the HYPRENE brand name; POM and LFT products; fiberglass honeycomb composite panels; polypropylene products; PA6/PA66 products; engineering plastics compounds; and high temperature resistant nylon/LCP. The company was formerly known as Hydro S&S Industries Limited and changed its name to Kingfa Science & Technology (India) Limited in March 2016. The company was incorporated in 1983 and is based in Pune, India. Kingfa Science & Technology (India) Limited is a subsidiary of M/s Kingfa Science & Technology Co. Ltd China.
Stock analysis
Kingfa Science & Technology (India) Limited (KINGFA) currently trades at ₹6,587, while our model-based Fair Value estimate is ₹2,324, 64.7% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹3,271 per share, and 0 of the 17 models we run sit above the ₹6,587 price.
Bear case: the Asset-Based group reads lowest at ₹691.84, and 17 of the 17 models stay below the price. Evidence for this calculation is medium.
Scenario range: ₹1,743 (bear) to ₹2,905 (bull), the price of ₹6,587 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Kingfa Science & Technology (India) Limited reported revenue of ₹20.0B in FY2026 versus ₹10.5B in FY2022, a compound +17.5%/yr. Reported net income was ₹1.9B in FY2026, compounding +56.8%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.
Key figures
Market cap ₹84.7B (≈ $879M) · P/E ratio 38.6 · P/S ratio 3.59 · EPS (TTM) ₹170.49 · Net margin 9.3% · Return on equity 17.4% · Return on assets (EBIT) 13.7% · Operating margin 15.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 75% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −65%, KINGFA screens richer than that median.
Fair Value models
Bear ₹1,743Fair Value ₹2,324Bull ₹2,905
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹86.41 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+14.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.0%
Start year 2021 (pandemic). Over 10 years: +20.3% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+48.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+48.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.48.0% vs 27.7%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 12%
Compare Kingfa Science & Technology (India) Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 705 stocks
Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score46 · Below median
Fair Value upside−64.7% · Bottom 25%
Profitability
Return on equity (TTM)17.4% · Top 25%
Return on assets10.6% · Top 25%
Net margin (TTM)9.3% · Above median
Operating margin (TTM)14.8% · Top 25%
Growth and dividend
Revenue growth23.2% · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)38.6× · Pricier than median
P/B6.05× · Priciest 25%
P/S (TTM)4.24× · Priciest 25%
EV/EBITDA29.2× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 48
PAST (return on equity)70· sector 25
HEALTH (low debt)100· sector 95
DIVIDEND (yield)0· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Kingfa Science & Technology (India) Limited (KINGFA) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of ₹2,324 versus a price of ₹6,587, about −65% upside (overvalued).
What is the fair value of KINGFA?
Our model-based fair value for Kingfa Science & Technology (India) Limited is ₹2,324 (as of Oct 2, 2026), built from audited fundamentals. The current price: ₹6,587.
What is the quality score of KINGFA?
Kingfa Science & Technology (India) Limited has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kingfa Science & Technology (India) Limited (KINGFA)?
Our model-based price target is the fair value of ₹2,324 (as of Oct 2, 2026) from 17 valuation models. Cautious scenario ₹1,743, optimistic scenario ₹2,905. It is a calculation from audited fundamentals, not an analyst target.
What is the Kingfa Science & Technology (India) Limited stock forecast for 2026?
Our models put fair value at ₹2,324, about −65% upside versus a price of ₹6,587 (overvalued). Cautious scenario ₹1,743, optimistic scenario ₹2,905. The calculation is refreshed regularly with new filings.
What is the revenue of Kingfa Science & Technology (India) Limited (KINGFA)?
Kingfa Science & Technology (India) Limited reported trailing-twelve-month revenue of about ₹22.2B (latest available figure, as of Oct 2, 2026).
What is the intrinsic value of Kingfa Science & Technology (India) Limited (KINGFA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kingfa Science & Technology (India) Limited it is ₹2,324 per share (as of Oct 2, 2026), against a price of ₹6,587. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Kingfa Science & Technology (India) Limited stock overvalued or undervalued in 2026?
As of Oct 2, 2026, KINGFA trades above its calculated fair value: price ₹6,587, fair value ₹2,324, a gap of about −65% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KINGFA?
No. The price is what the market pays today (₹6,587); the fair value is what the company's own numbers justify (₹2,324). For Kingfa Science & Technology (India) Limited the two are ₹4,262 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kingfa Science & Technology (India) Limited worth?
The market values Kingfa Science & Technology (India) Limited at about ₹84.7B (market capitalisation, as of Oct 2, 2026). Per share that is ₹6,587; our models calculate a fair value of ₹2,324 per share.
What do the bullish and bearish scenarios say about KINGFA?
Our models span a range for Kingfa Science & Technology (India) Limited: cautious scenario ₹1,743, base ₹2,324, optimistic ₹2,905 per share (as of Oct 2, 2026, price ₹6,587). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of KINGFA?
Kingfa Science & Technology (India) Limited trades at a price-to-earnings ratio of 38.6 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹2,324 is built from several models across several years. Other multiples: P/B 6.1, P/S 4.2, EV/EBITDA 29.2.
How solid is the balance sheet of Kingfa Science & Technology (India) Limited (KINGFA)?
Balance-sheet figures for Kingfa Science & Technology (India) Limited (as of Oct 2, 2026): return on equity 17.4%. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is KINGFA from its 52-week high?
Kingfa Science & Technology (India) Limited trades at ₹6,587, at its 52-week high of ₹6,587 and 75% above the low of ₹3,759 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹2,324 is for.
Which stocks are comparable to Kingfa Science & Technology (India) Limited?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kingfa Science & Technology (India) Limited stock attractive at the current price?
The data as of Oct 2, 2026: price ₹6,587, calculated fair value ₹2,324 (−65%), Quality Score 46/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KINGFA calculated?
We run Kingfa Science & Technology (India) Limited through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹2,324, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Kingfa Science & Technology (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kingfa Science & Technology (India) Limited (KINGFA)?
The closing price on Oct 1, 2026 was ₹6,587. Our model-based fair value is ₹2,324, about −65% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kingfa Science & Technology (India) Limited right now?
The price sits above even our optimistic bull case (₹2,905). The favourable scenario is already priced in. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Kingfa Science & Technology (India) Limited (KINGFA) come from?
Earnings per share at Kingfa Science & Technology (India) Limited grew +31.2 % a year from 2016 to 2026. Broken into its drivers: revenue per share +15.8 %, EBIT margin +11.6 %, tax rate +1.4 %, residual (interest, one-offs) +0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Kingfa Science & Technology (India) Limited
How large is the market capitalisation of Kingfa Science & Technology (India) Limited (KINGFA)?
The market capitalisation of Kingfa Science & Technology (India) Limited is ₹84.7B (≈ $879M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kingfa Science & Technology (India) Limited (KINGFA)?
The price-to-sales ratio of Kingfa Science & Technology (India) Limited is 3.59 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kingfa Science & Technology (India) Limited (KINGFA)?
Earnings per share at Kingfa Science & Technology (India) Limited are ₹170.49 (price ÷ EPS = P/E 38.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Kingfa Science & Technology (India) Limited (KINGFA)?
The net margin of Kingfa Science & Technology (India) Limited is 9.3% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kingfa Science & Technology (India) Limited (KINGFA)?
The return on equity (ROE) of Kingfa Science & Technology (India) Limited is 17.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kingfa Science & Technology (India) Limited (KINGFA)?
On an EBIT basis the return on assets of Kingfa Science & Technology (India) Limited is 13.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kingfa Science & Technology (India) Limited (KINGFA)?
The operating margin of Kingfa Science & Technology (India) Limited is 15.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kingfa Science & Technology (India) Limited (KINGFA)?
Revenue at Kingfa Science & Technology (India) Limited is growing +49.1% versus a year earlier (3y avg +12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kingfa Science & Technology (India) Limited (KINGFA)?
Earnings per share at Kingfa Science & Technology (India) Limited are growing +80.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Kingfa Science & Technology (India) Limited (KINGFA) generate?
The free cash flow of Kingfa Science & Technology (India) Limited is −₹436M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Kingfa Science & Technology (India) Limited (KINGFA) hold?
Kingfa Science & Technology (India) Limited holds more cash than debt, ₹4.1B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Kingfa Science & Technology (India) Limited in the live analysis
One click puts Kingfa Science & Technology (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
